Yahoo
NasdaqCM - Delayed Quote USD

CervoMed Inc. (CRVO)

2.5600 +0.0200 (+0.79%)
At close: September 4 at 4:00:01 PM EDT
2.5400 -0.0200 (-0.78%)
After hours: September 4 at 7:30:03 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
31,164.7930
28,294.8770
18,227.1310
7,812.8950
3,475.5340
Operating Income
-31,164.7930
-28,294.8770
-18,227.1310
-7,812.8950
-3,475.5340
Net Non Operating Interest Income Expense
812.0090
1,336.8370
1,937.4270
219.4300
61.6390
Other Income Expense
3.0410
-8.3270
-0.9910
5,421.5920
-2,389.1520
Pretax Income
-30,349.7430
-26,966.3670
-16,290.6950
-2,171.8730
-5,803.0470
Tax Provision
--
--
--
--
0
Net Income Common Stockholders
-30,349.7430
-26,966.3670
-16,290.6950
-2,171.8730
-5,803.0470
Diluted NI Available to Com Stockholders
-30,349.7430
-26,966.3670
-16,290.6950
-2,171.8730
-5,803.0470
Basic EPS
-3.21
-2.98
-2.02
-0.82
-11.20
Diluted EPS
-3.21
-2.98
-2.02
-0.82
-11.20
Basic Average Shares
9,505.1780
9,041.7600
8,073.1550
2,661.4160
518.1400
Diluted Average Shares
9,505.1780
9,041.7600
8,073.1550
2,661.4160
518.1400
Total Operating Income as Reported
-31,164.7930
-28,294.8770
-18,227.1310
-7,812.8950
-3,475.5340
Total Expenses
31,164.7930
28,294.8770
18,227.1310
7,812.8950
3,475.5340
Net Income from Continuing & Discontinued Operation
-30,349.7430
-26,966.3670
-16,290.6950
-2,171.8730
-5,803.0470
Normalized Income
-30,349.7430
-26,966.3670
-16,290.6950
-2,171.8730
-5,803.0470
Interest Income
812.0090
1,336.8370
1,937.4270
219.4300
62.2260
Interest Expense
--
--
--
0
0.5870
Net Interest Income
812.0090
1,336.8370
1,937.4270
219.4300
61.6390
EBIT
-31,164.7930
-28,294.8770
-18,227.1310
-7,812.8950
-5,802.4600
EBITDA
-31,164.7930
-28,294.8770
-18,227.1310
-7,812.8950
-5,802.4600
Reconciled Depreciation
--
--
--
--
0
Net Income from Continuing Operation Net Minority Interest
-30,349.7430
-26,966.3670
-16,290.6950
-2,171.8730
-5,803.0470
Total Unusual Items Excluding Goodwill
--
--
--
--
0
Total Unusual Items
--
--
--
--
0
Normalized EBITDA
-31,164.7930
-28,294.8770
-18,227.1310
-7,812.8950
-5,802.4600
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 5/23/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: